Bimatoprost
11 Inquiries
155206-00-1
99%
2026-08-11
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Inquiry History
-
Description
ProductName Bimatoprost Cat No CEI-0387 Description Bimatoprost Alias Lumigan CAS No 155206-00-1 Molecular Weight 415.57 Purity >99% Storage 2 years at -20centigrade Powder Synonyms Lumigan Targets PGF synthase Molecular Formula C25H37NO4 Chemical Name (Z)-7-((1R,2R,3S,5S)-3,5-dihydroxy-2-((E)-3-hydroxy-5-phenylpent-1-enyl)cyclopentyl)-N-ethylhept-5-enamide Solubility DMSO 36 mg/mL, Water In vitro Bimatoprost is a prostaglandin analog used topically (as eye drops) to control the progression of glaucoma and in the management of ocular hypertension. It reduces intraocular pressure (IOP) by increasing the outflow of aqueous fluid from the eyes. It has also been used and prescribed off-label to lengthen eyelashes. category Hormones and the Endocrine System(c1412) cas_num 155206-00-1 Basic Info-
Product Name:
Bimatoprost
Other Name:5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-,(5Z)-;5-Heptenamide,7-[3,5-dihydroxy-2-(3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl]-N-ethyl-,[1R-[1α(Z),2β(1E,3S*),3α,5α]]-;5-Heptenamide,7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-pentenyl]cyclopentyl]-N-ethyl-,(5Z)-;(5Z)-7-[(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl]-N-ethyl-5-heptenamide;Bimatoprost;AGN 192024;Lumigan;Prostamide;Latisse;17-Phenyltrinor-PGF2α ethylamide;267244-98-4
CAS No.:155206-00-1
Molecular Formula:C25H37NO4
InChIKeys:InChIKey=AQOKCDNYWBIDND-FTOWTWDKSA-N
Molecular Weight:415.57
Exact Mass:415.57
EC Number:2017-001-1
Categories:
Characteristics-
PSA:
89.8
Appearance:solid
Density:1.145±0.06 g/cm3(Predicted)
Melting Point:67-68 °C
Boiling Point:629.8±55.0 °C(Predicted)
Flash Point:334.7±31.5 °C
Refractive Index:1.591
Storage Conditions:−20°C
Hazard IdentificationClassification of the substance or mixture
Acute toxicity - Category 4, Dermal
Eye irritation, Category 2
Germ cell mutagenicity, Category 1B
Reproductive toxicity, Category 1B
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H312 Harmful in contact with skin
H319 Causes serious eye irritation
H340 May cause genetic defects
H360 May damage fertility or the unborn child
Precautionary statement(s) Prevention P280 Wear protective gloves/protective clothing/eye protection/face protection/hearing protection/...
P264 Wash ... thoroughly after handling.
P203 Obtain, read and follow all safety instructions before use.
Response P302+P352 IF ON SKIN: Wash with plenty of water/...
P317 Get medical help.
P321 Specific treatment (see ... on this label).
P362+P364 Take off contaminated clothing and wash it before reuse.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P318 IF exposed or concerned, get medical advice.
Storage P405 Store locked up.
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Inquiry History11 Inquiries
Country Product Purchase Quantity Date Posted 
United States
99% Purity Bimatoprost Raw Powder CAS 155206-00-1 Bimatoprost
1 G Jan 8, 2024 
India
5Z)-7-{(1R,2R,3R,5S)-3,5-Dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenyl-1-penten-1-yl]cyclopentyl}-N-ethyl-5-heptenamid
100 G Apr 30, 2024 
United Kingdom
Bimatoprost
1 G Oct 31, 2025 
Denmark
bimatoprost
10 G Jun 30, 2026 
United Arab Emirates
Bimatoprost 99% white powder muhuang
100 G Sep 6, 2023 
Bangladesh
Bimatoprost
5 G Nov 14, 2024 
Lebanon
bimatoprost
1 KG May 11, 2024 
Poland
Medical Uses Bimatoprost Lumigan CAS NO.155206-00-1
1 G Nov 6, 2023
United Kingdom
Bimatoprost
1 G May 31, 2026 
Pakistan
Bimatoprost
4.00 G Jul 3, 2025
United Kingdom
Bimatoprost
1 MT Jan 6, 2025 Post an enquiry for this product